VM Discovery
Drug design and optimization technology platform.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | $12.6m | Series C | |
| Total Funding | 000k | ||
VM Discovery, Inc. was a drug design and discovery company founded in 2001 and headquartered in Fremont, California. The firm focused on developing a drug design and optimization technology to identify multi-property optimized drug candidates for pharmaceutical and biotechnology partners.
The company's core technology, VMOptimizer, was a multivariate drug design platform. It conducted parallel multi-property modeling, optimization, and virtual screening to select small molecule drug candidates with balanced potency. The objective was to enable the production of new medicines more quickly and with fewer resources. The company's business model involved collaborating with pharmaceutical and biotech companies to provide internally optimized drug candidates.
Throughout its history, VM Discovery secured funding from various sources, including venture capital and grants from institutions like the National Cancer Institute. Investors included ONSET Ventures and Amkey Ventures. In June 2012, the company spun out a novel ion channel blocker program into a new entity, VM Therapeutics, which secured $8 million in venture funding. According to PitchBook, VM Discovery ceased operations as of July 2021.
Keywords: drug design, drug discovery, drug optimization, biotechnology, VMOptimizer, small molecule drugs, virtual screening, multivariate modeling, pharmaceutical collaboration, life sciences